Renasant reports Q3 results
Renasant (RNST) reported Q3 non-GAAP EPS of $0.86 and net income of $78.95M, up 32.0% year-over-year. The company also announced a $140M deal with Commercial Bank & Trust, expecting ~4% EPS accretion and a Q1 2027 close.
How this was made
The 30-second read
Why it matters
Traders may reassess RNST’s earnings power based on the reported Q3 profitability and update deal-driven valuation assumptions using the stated accretion target and Q1 2027 close timing.
Market read
Company-specific earnings numbers and disclosed transaction terms provide actionable inputs for RNST positioning, though the excerpt lacks deeper balance-sheet and guidance details.
What to watch
The article excerpt does not include credit quality, NIM, deposit trends, or guidance for the current quarter, which are often the key drivers of regional bank re-ratings after earnings.
Background
The piece summarizes Renasant’s Q3 results and highlights an announced $140M commercial bank and trust transaction plus a merger deal with Commercial Holding.
Ticker impact
Renasant reports Q3 non-GAAP EPS of $0.86 and net income of $78.95M, plus a $140M commercial bank and trust deal targeting ~4% EPS accretion.
Likely modest upward bias as investors price in the reported profitability and the stated EPS accretion from the announced deal, offset by deal-close uncertainty.
The article provides specific Q3 earnings figures and new deal details (size, accretion target, and targeted close timing), which are direct inputs to valuation and risk.
Market effects
Adds incremental data on regional bank dealmaking and accretion narratives, which can influence sentiment toward M&A-capable community/regional lenders.
Primarily impacts US regional banking sentiment rather than broad macro rates or credit markets.
Low, as the disclosed events are company-specific and US-focused.
Counterpoint
The deal’s ~4% EPS accretion is a target, and execution, regulatory approvals, and integration could delay or reduce realized accretion.
Key entities
- companyRenasant Corporation
US regional bank reporting Q3 results and announcing a $140M commercial bank and trust deal targeting EPS accretion.
- companyCommercial Holding
Named as a counterparty in a merger deal with Renasant.



